These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 12653794)

  • 21. Attenuation of early and late phase allergen-induced bronchoconstriction in asthmatic subjects by a 5-lipoxygenase activating protein antagonist, BAYx 1005.
    Hamilton AL; Watson RM; Wyile G; O'Byrne PM
    Thorax; 1997 Apr; 52(4):348-54. PubMed ID: 9196518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of the novel SHIP1 activator AQX-1125 on allergen-induced responses in mild-to-moderate asthma.
    Leaker BR; Barnes PJ; O'Connor BJ; Ali FY; Tam P; Neville J; Mackenzie LF; MacRury T
    Clin Exp Allergy; 2014 Sep; 44(9):1146-53. PubMed ID: 25040039
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of low-dose ciclesonide on allergen-induced responses in subjects with mild allergic asthma.
    Gauvreau GM; Boulet LP; Postma DS; Kawayama T; Watson RM; Duong M; Deschesnes F; De Monchy JG; O'Byrne PM
    J Allergy Clin Immunol; 2005 Aug; 116(2):285-91. PubMed ID: 16083781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Setipiprant, a selective CRTH2 antagonist, reduces allergen-induced airway responses in allergic asthmatics.
    Diamant Z; Sidharta PN; Singh D; O'Connor BJ; Zuiker R; Leaker BR; Silkey M; Dingemanse J
    Clin Exp Allergy; 2014 Aug; 44(8):1044-52. PubMed ID: 24964348
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Postallergen inhaled budesonide reduces late asthmatic response and inhibits the associated increase of airway responsiveness to methacholine in asthmatics.
    Paggiaro PL; Dente FL; Morelli MC; Bancalari L; Di Franco A; Giannini D; Vagaggini B; Bacci E; Fabbri LM; Giuntini C
    Am J Respir Crit Care Med; 1994 Jun; 149(6):1447-51. PubMed ID: 8004297
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ciclesonide is more effective than budesonide in the treatment of persistent asthma.
    Ukena D; Biberger C; Steinijans V; von Behren V; Malek R; Weber HH; Beck E; Linnhoff A
    Pulm Pharmacol Ther; 2007; 20(5):562-70. PubMed ID: 16962345
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of cyclosporin A on the allergen-induced late asthmatic reaction.
    Sihra BS; Kon OM; Durham SR; Walker S; Barnes NC; Kay AB
    Thorax; 1997 May; 52(5):447-52. PubMed ID: 9176537
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized comparison of ciclesonide 160 and 640 microg/day in severe asthma.
    Bateman ED; Cheung D; Lapa e Silva J; Göhring UM; Schäfer M; Engelstätter R
    Pulm Pharmacol Ther; 2008; 21(3):489-98. PubMed ID: 18178494
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of an interleukin-4 variant on late phase asthmatic response to allergen challenge in asthmatic patients: results of two phase 2a studies.
    Wenzel S; Wilbraham D; Fuller R; Getz EB; Longphre M
    Lancet; 2007 Oct; 370(9596):1422-31. PubMed ID: 17950857
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of MK-0591, a novel 5-lipoxygenase activating protein inhibitor, on leukotriene biosynthesis and allergen-induced airway responses in asthmatic subjects in vivo.
    Diamant Z; Timmers MC; van der Veen H; Friedman BS; De Smet M; Depré M; Hilliard D; Bel EH; Sterk PJ
    J Allergy Clin Immunol; 1995 Jan; 95(1 Pt 1):42-51. PubMed ID: 7822663
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the efficacy and safety of ciclesonide 160 microg once daily vs. budesonide 400 microg once daily in children with asthma.
    von Berg A; Engelstätter R; Minic P; Sréckovic M; Garcia Garcia ML; Latoś T; Vermeulen JH; Leichtl S; Hellbardt S; Bethke TD
    Pediatr Allergy Immunol; 2007 Aug; 18(5):391-400. PubMed ID: 17617808
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapid effect of inhaled ciclesonide in asthma: a randomized, placebo-controlled study.
    Erin EM; Zacharasiewicz AS; Nicholson GC; Tan AJ; Neighbour H; Engelstätter R; Hellwig M; Kon OM; Barnes PJ; Hansel TT
    Chest; 2008 Oct; 134(4):740-745. PubMed ID: 18403668
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of hydrofluoroalkane formulations of ciclesonide 400 microg once daily vs fluticasone 250 microg twice daily on methacholine hyper-responsiveness in mild-to-moderate persistent asthma.
    Lee DK; Haggart K; Currie GP; Bates CE; Lipworth BJ
    Br J Clin Pharmacol; 2004 Jul; 58(1):26-33. PubMed ID: 15206989
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Airway and systemic effects of hydrofluoroalkane formulations of high-dose ciclesonide and fluticasone in moderate persistent asthma.
    Lee DK; Fardon TC; Bates CE; Haggart K; McFarlane LC; Lipworth BJ
    Chest; 2005 Mar; 127(3):851-60. PubMed ID: 15764767
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of an inhaled leukotriene antagonist, L-648,051, on early and late asthmatic reactions and subsequent increase in airway responsiveness in man.
    Bel EH; Timmers MC; Dijkman JH; Stahl EG; Sterk PJ
    J Allergy Clin Immunol; 1990 Jun; 85(6):1067-75. PubMed ID: 2191993
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the efficacy of ciclesonide 160 microg QD and budesonide 200 microg BID in adults with persistent asthma: a phase III, randomized, double-dummy, open-label study.
    Niphadkar P; Jagannath K; Joshi JM; Awad N; Boss H; Hellbardt S; Gadgil DA
    Clin Ther; 2005 Nov; 27(11):1752-63. PubMed ID: 16368446
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparable efficacy of ciclesonide once daily versus fluticasone propionate twice daily in asthma.
    Buhl R; Vinkler I; Magyar P; Györi Z; Rybacki C; Middle MV; Escher A; Engelstätter R
    Pulm Pharmacol Ther; 2006; 19(6):404-12. PubMed ID: 16310388
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhaled anti-TSLP antibody fragment, ecleralimab, blocks responses to allergen in mild asthma.
    Gauvreau GM; Hohlfeld JM; FitzGerald JM; Boulet LP; Cockcroft DW; Davis BE; Korn S; Kornmann O; Leigh R; Mayers I; Watz H; Grant SS; Jain M; Cabanski M; Pertel PE; Jones I; Lecot JR; Cao H; O'Byrne PM
    Eur Respir J; 2023 Mar; 61(3):. PubMed ID: 36822634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of three ciclesonide doses vs placebo in children with asthma: the RAINBOW study.
    Pedersen S; Potter P; Dachev S; Bosheva M; Kaczmarek J; Springer E; Dunkel J; Engelstätter R
    Respir Med; 2010 Nov; 104(11):1618-28. PubMed ID: 20619624
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of inhaled thiorphan on allergen-induced airway responses in asthmatic subjects.
    Diamant Z; Van der Veen H; Kuijpers EA; Bakker PF; Sterk PJ
    Clin Exp Allergy; 1996 May; 26(5):525-32. PubMed ID: 8735864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.